American Journal of Clinical Nutrition, Vol 64, 894-902, Copyright © 1996 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Assessment of vitamin K status in human subjects administered "minidose" warfarin

AU Bach, SA Anderson, AL Foley, EC Williams and JW Suttie
Department of Nutritional Sciences, College of Agricultural and Life Sciences, University of Wisconsin-Madison 53706, USA.

Vitamin K is required to convert specific glutamyl residues in a limited number of proteins to gamma-carboxyglutamyl residues. The response of various measures of vitamin K insufficiency to the administration of 1 mg/d of the vitamin K antagonist warfarin was studied in two groups of nine older (55-75 y) or younger (20-28 y) subjects. The most consistent and extensive alteration was an increase in the concentration of serum under-gamma-carboxylated osteocalcin followed by increased immunochemical detection of plasma under-gamma- carboxylated prothrombin (PIVKA-II), and by a decreased urinary excretion of gamma-carboxyglutamic acid. Plasma concentrations of prothrombin were altered by this treatment but prothrombin times, factor VII activity, prothrombin F-1 x 2 concentrations, and a less sensitive assay for under-gamma-carboxylated prothrombine were not. The concentration of serum under-gamma-carboxylated osteocalcin was lower when subjects consumed 1 mg vitamin K/d than when they consumed their normal diet.

This article has been cited by other articles:

				D. A. Pearson Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544. [Abstract] [Full Text] [PDF]

				M. Bern Observations on Possible Effects of Daily Vitamin K Replacement, Especially Upon Warfarin Therapy JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 388 - 398. [Abstract] [Full Text] [PDF]

				S. L Booth, I. Golly, J. M Sacheck, R. Roubenoff, G. E Dallal, K. Hamada, and J. B Blumberg Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status Am. J. Clinical Nutrition, July 1, 2004; 80(1): 143 - 148. [Abstract] [Full Text] [PDF]

				S. L Booth, K. E Broe, D. R Gagnon, K. L Tucker, M. T Hannan, R. R McLean, B. Dawson-Hughes, P. W. Wilson, L A. Cupples, and D. P Kiel Vitamin K intake and bone mineral density in women and men Am. J. Clinical Nutrition, February 1, 2003; 77(2): 512 - 516. [Abstract] [Full Text] [PDF]

				S. L Booth, A. H Lichtenstein, M. O'Brien-Morse, N. M McKeown, R. J Wood, E. Saltzman, and C. M Gundberg Effects of a hydrogenated form of vitamin K on bone formation and resorption Am. J. Clinical Nutrition, December 1, 2001; 74(6): 783 - 790. [Abstract] [Full Text]

				N. C Binkley, D. C Krueger, J. A Engelke, A. L Foley, and J. W Suttie Vitamin K supplementation reduces serum concentrations of under-{gamma}-carboxylated osteocalcin in healthy young and elderly adults Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1523 - 1528. [Abstract] [Full Text] [PDF]

				S. L Booth, M. E O'Brien-Morse, G. E Dallal, K. W Davidson, and C. M Gundberg Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults Am. J. Clinical Nutrition, September 1, 1999; 70(3): 368 - 377. [Abstract] [Full Text] [PDF]

				M. Rashid, P. Durie, M. Andrew, D. Kalnins, J. Shin, M. Corey, E. Tullis, and P. B Pencharz Prevalence of vitamin K deficiency in cystic fibrosis Am. J. Clinical Nutrition, September 1, 1999; 70(3): 378 - 382. [Abstract] [Full Text] [PDF]

				A. K. Garber, N. C. Binkley, D. C. Krueger, and J. W. Suttie Comparison of Phylloquinone Bioavailability from Food Sources or a Supplement in Human Subjects J. Nutr., June 1, 1999; 129(6): 1201 - 1203. [Abstract] [Full Text]

				S. L. Booth and J. W. Suttie Dietary Intake and Adequacy of Vitamin K1 J. Nutr., May 1, 1998; 128(5): 785 - 788. [Abstract] [Full Text]